Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease. - Mengel D; Soter E; Ott JM; Wacker M; Leyva A; Peters O; Hellmann-Regen J; Schneider LS; Wang X; Priller J; Spruth E; Altenstein S; et al. (Molecular psychiatry, 2025)